Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B. Sahin, Mark N. Adams|Cancers|2021Cited by 11